Search

everythinglearnresearchcommunity

for

Search:↓

Testosterone therapy can improve sexual desire and function in postmenopausal women but should be used cautiously and not based solely on testosterone levels.

Testosterone may have a dual role in COVID-19, potentially worsening outcomes in men, and testosterone therapy could help some patients, but more research is needed.

The removed ovarian tumor was a rare type of blood vessel tumor that improved the patient's symptoms and hormone levels after surgery.

Metformin and rosiglitazone improve blood vessel function in women with PCOS, with metformin also reducing insulin resistance and testosterone levels.

COVID-19 temporarily affects male reproductive health, but sperm and testosterone levels generally return to normal after three months.

Finasteride and dutasteride are effective for long-term treatment of enlarged prostates but have sexual side effects and a risk of high-grade prostate cancer.

Higher DHT in male baldness may protect against prostate cancer.

Scalp hair thinning in women with PCOS is linked to metabolic issues like abnormal glucose tolerance, high LDL, and skipped meals.

Free testosterone is the most common hormone marker in PCOS, and age affects DHEAS levels.

The Cyp11a1 gene variation has a weak link to PCOS, but higher di-hydro-testosterone levels are found in PCOS patients.

Increased free testosterone can lead to stronger bones and less body fat but also higher risks of prostate cancer, hair loss, spine issues, and high blood pressure.

5-α-reductase inhibitors reduce prostate cancer risk but may cause sexual dysfunction and don't affect high-grade tumor or death rates.

Finasteride helps prevent kidney stones, but side effects need more research.

Hair loss links to high blood pressure, high fat levels, and metabolic issues, suggesting early heart disease screening.

Finasteride lowers PSA levels and prostate size, requiring adjusted PSA interpretation for accurate cancer screening.

A new method accurately measures nine steroid hormones in human serum with high sensitivity.

Laparoscopic ovarian drilling improves menstrual cycles, hormone levels, and pregnancy rates in women with PCOS.

Women with PCOS have higher 5alpha-reductase activity, affecting steroid levels.

A pregnant woman's skin condition improved after giving birth, possibly due to high estrogen levels during pregnancy.

Testosterone and finasteride raise insulin and zinc, lower chromium in male rats.

Lifestyle changes can improve body composition, excess male hormone levels, and insulin resistance in women with PCOS.

An mFG score of 7 or higher indicates hirsutism in Filipino women, often linked to higher free testosterone levels.

Indian women with PCOS from Delhi and Srinagar show different symptoms, with Delhi women having higher obesity and blood sugar issues, and Srinagar women showing more hair growth and testosterone levels.

PCOS often causes acne, dark skin patches, excess hair, and hair loss, linked to hormone levels and obesity.

Testosterone pellet therapy may better address hormone imbalances in aging by focusing on local hormone production and symptom relief.

Certain gene variations in AKT2 are more common in women with PCOS and are linked to higher levels of specific hormones and symptoms.

Women with PCOS who have low SHBG are more likely to have low good cholesterol and metabolic syndrome.

Finasteride and CPA-EE2 equally reduce hirsutism, but affect hormone levels differently.

White wax and policosanol from white wax effectively reduced hair loss and promoted hair growth in mice better than a known hair growth drug.

Quick, selective detection of tadalafil and finasteride in human plasma developed.